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Abstract 
 
Previous studies have shown that a two-week treatment with 40 mg/kg corticosterone 
(CORT) in rats suppresses hippocampal neurogenesis and decreases hippocampal 
brain derived neurotrophic factor (BDNF) levels and impairs spatial learning, all of 
which could be counteracted by voluntary wheel running. BDNF and insulin-like 
growth factor (IGF-1) have been suggested to mediate physical exercise-enhanced 
hippocampal neurogenesis and cognition. Here we examined whether such 
running-elicited benefits were accompanied by corresponding changes of peripheral 
BDNF and IGF-1 levels in a rat model of stress. We examined the effects of acute (5 
days) and chronic (4 weeks) treatment with CORT and/or wheel running on (1) 
hippocampal cell proliferation, (2) spatial learning and memory and (3) plasma levels 
of BDNF and IGF-1. Acute CORT treatment improved spatial learning without altered 
cell proliferation compared to vehicle treatment. Acute CORT-treated non-runners 
showed an increased trend in plasma BDNF levels together with a significant increase 
in hippocampal BDNF levels. Acute running showed no effect on cognition, cell 
proliferation and peripheral BDNF and IGF-1 levels. Conversely, chronic CORT 
treatment in non-runners significantly impaired spatial learning and suppressed cell 
proliferation in association with a decreased trend in plasma BDNF level and a 
significant increase in hippocampal BDNF levels. Running counteracted cognitive 
deficit and restored hippocampal cell proliferation following chronic CORT treatment; 
but without corresponding changes in plasma BDNF and IGF-1 levels. The results 
suggest that the beneficial effects of acute stress on cognitive improvement may be 
mediated by BDNF-enhanced synaptic plasticity that is hippocampal cell 
proliferation-independent, whereas chronic stress may impair cognition by decreasing 
hippocampal cell proliferation and BDNF levels. Furthermore, the results indicate a 
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trend in changes of plasma BDNF levels associated with a significant alteration in 
hippocampal levels, suggesting that treatment with running/CORT for four weeks 
may induce a change in central levels of hippocampal BDNF level, which may not 
lead to a significant change in peripheral levels.  
 
Key words: corticosterone, BDNF, IGF-1, hippocampal cell proliferation, voluntary 
running, stress 
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Physical exercise enhances learning and memory and exerts antidepressive effects 
(Ernst et al., 2006, Yau et al., 2011a). Animal studies have shown that free wheel 
running improves spatial learning in concurrence with changes in hippocampal 
plasticity, including increased neurogenesis, enhanced long-term potentiation (LTP) 
(van Praag et al., 1999a, van Praag et al., 1999b), and elevated expression of 
brain-derived neurotrophic factors (BDNF) (Cotman and Berchtold, 2002, Farmer et 
al., 2004, Cotman et al., 2007).  
 
Enhanced hippocampal neurogenesis from physical exercise (van Praag et al., 1999b) 
is putatively regarded a basis for improving cognitive function (van Praag et al., 
1999a, van Praag et al., 2005) and counteracting depression (Ernst et al., 2006).  In 
contrast, reduced neurogenesis by chronic stress or by high doses of glucocorticoid 
treatment (Gould et al., 1992, Gould et al., 1998) has been associated with cognitive 
deficits and linked to the psychopathology of clinical depression (Duman et al., 1997, 
Ernst et al., 2006). Ablation of neurogenesis in animal studies further indicates that 
hippocampal neurogenesis potentially mediates the beneficial effects of exercise on 
cognitive performance and depressive disorders (Clark et al., 2008, Lafenetre et al., 
2010, Yau et al., 2011b). 
 
Several neurotrophic factors, such as BDNF and insulin-like growth factor (IGF-1) 
have been suggested to be potential mediators for the exercise-derived hippocampal 
plasticity (Cotman and Berchtold, 2002, Cotman et al., 2007). Increased neurogenesis 
and improved cognitive function by exercise are in parallel with  BDNF 
up-regulation in the brain (Cotman and Berchtold, 2002, Vaynman et al., 2004, Zheng 
et al., 2006),  possibly caused by the exercise-triggered uptake of IGF-1 into the 
brain (Carro et al., 2000). In a study conducted by Trejo et al. mutant mice with low 
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levels of serum IGF-I showed reduced hippocampal neurogenesis together with 
impaired spatial learning which could not be reversed by running (Trejo et al., 2008). 
This suggests that exercise-induced neurogenesis may be mediated by the entry of 
peripheral IGF-1 into the brain (Trejo et al., 2001). Thus, peripheral BDNF and IGF-1 
levels are increasingly seen as potential biomarkers for evaluating the 
exercise-elicited cognitive improvement in studies involving human subjects. 
  
 
Clinical observation has demonstrated a decrease in blood BDNF level in depressive 
patients and an increase in serum BDNF level after antidepressant treatment 
(Martinowich et al., 2007, Molendijk et al., 2011). Since it is not feasible to directly 
measure the alteration of hippocampal neurogenesis in live human brain tissues, 
clinical studies have most exclusively relied on examining the serum or plasma levels 
of neurotrophins following interventions. It has recently been shown that the 
alteration in blood BDNF level can reflect its release from the brain (Klein et al., 2011) 
where contributes to the increase in plasma BDNF in response to exercise (Rasmussen 
et al., 2009).  Given the positive association between hippocampal neurogenesis, 
levels of neurotrophinns (e.g. BDNF and IGF-1) and cognitive improvement after 
exercise intervention suggested by other studies, it would be interesting to investigate 
whether alterations of peripheral neurotrophins are accompanied by the corresponding 
changes of hippocampal cell proliferation. A positive correlation would justify the 
rational to apply such peripheral biomarkers in evaluating cognitive state following 
exercise for translational studies on human subjects.  
 
In a rat model of stress using repeated CORT injections, we have previously shown 
that voluntary wheel running for 14 days could restore the decrease in hippocampal 
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cell proliferation and attenuate learning impairment together with enhanced 
expression of BDNF protein levels (Yau et al., 2011b). However, it is unclear whether 
peripheral changes of BDNF and IGF-1 correspond to alteration in hippocampal cell 
proliferation. Hence, we investigated the effects of acute and chronic CORT 
treatments, with or without running on hippocampal-dependent learning and memory, 
cell proliferation in the hippocampus, and peripheral levels of BDNF and IGF-1. 
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EXPERIMENTAL PROCEDURES 
 
Animals and housing conditions 
All experimental procedures were approved and followed the guidelines of the 
Committee on the Use of Live Animals in Teaching and Research, The University of 
Hong Kong. Adult male Sprague-Dawley rats (250±20 g) were housed individually 
with unlocked running wheels for runners or locked wheels for non-runners. Animals 
were divided into several groups including: the vehicle-treated non-runners (CtrlN) 
and runners (CtrlR), the 40mg/kg CORT-treated non-runners (40mgN) and runners 
(40mgR). These were then further subdivided into either acute (5 days) or chronic (28 
days) treatment groups (n=4-6 per group). All rats were kept on a 12 h light-dark 
cycle with ad libitum access to food and water.  
 
Animal treatments 
After adaptation in the cages with locked wheels for two days, the rats received daily 
treatments with sesame oil or 40 mg/kg CORT and subjected to unlocked or locked 
wheels for 5 days (acute treatment) or 28 days (chronic treatment). The treatment was 
started on Day 3 and ended on Day 7 for acute treatment or on Day 30 for chronic 
treatment. Corticosterone (Sigma-Aldrich, St Louis, MO) was prepared and injected 
subcutaneously according to the method of Hellsten et al.(Hellsten et al., 2002). 
Bromodeoxyuridine (BrdU, 50mg/kg body weight) was dissolved in normal saline 
and administered intraperitoneally in 12-hr intervals during the last 3 days of the 
treatments for labeling proliferating cells. This was followed by the Morris water 
maze task. Changes in body weight was monitored weekly, and the adrenal weight 
was measured after sacrificing the animals (see Figure 1). 
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Exercise training 
Runners were housed singly in cages equipped with running wheels (diameter 31.8 cm; 
width 10 cm; Nalgene Nunc International, Rochester, NY). Rats were allowed to run 
freely for 5 or 28 days and wheels were then locked during the water maze task. Wheel 
revolutions were recorded using the VitalViewer software (Mini Mitter Company, Inc, 
Bend, OR). Non-runners were housed individually in identical cages with locked 
wheels.  
 
 
Morris water maze task 
Spatial learning and memory was examined using the water maze task with a hidden 
platform 0.5 cm below the water surface. The water was made opaque by adding 
non-toxic ink. The test was conducted for five consecutive days with four trials per 
day with the platform located in the same position. Animals were brought into the 
testing room 30 min prior to the test for adaptation. The starting points were randomly 
assigned to each animal every day. The latency for the animals to reach the platform 
was recorded by a trained observer. If the animals did not find the platform after a 
maximum of 60 s, it was brought to the platform for 20 s and assigned a score of 60 s. 
The animals were then returned to the cage and given a 4 min inter-trial rest.  
On the sixth day, a probe trial was performed with the platform removed from the 
tank. Time spent in the target area in the probe trial was analyzed using SmartJunior 
software (Panlab, Spain). The target area was defined as a circular area with the 
diameter of 20 cm measured from the centre of the platform as previously applied 
(Yau et al., 2011b). 
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Sucrose preference test 
The test was performed after three or four weeks of CORT treatments. The rats were 
firstly supplied with 1 % sucrose in place of water for 24 hr. They were then offered 
simultaneously one bottle containing 1 % sucrose and one bottle with tap water for 24 
hr. The position of the two bottles was swapped after 12 hr. The consumption of water 
and sucrose was recorded by weighing the bottles before and after the test. The 
sucrose preference was presented as the percentage of total amount of liquid 
consumption.  
 
Tissue preparation 
Twenty-four hours after the end of the water maze task, animals were anesthetized 
with a mixture (2:1, v/v) of ketamine 200 mg/ml and xylazine and transcardially 
perfused with 0.9 % saline solution, followed by 4 % paraformaldehyde for 20 min. 
Brains were removed from the skull and posted fixed overnight at 4 °C. After that, the 
brains were placed in 30 % sucrose solution until they sank. Twelve series of 40 μm 
coronal sections were cut with a freezing sliding microtome (Model 860; American 
Optical, Buffalo, NY) and the brain slices were stored in cryoprotectant until use. The 
cryoprotectant consists of 200 ml 0.1 M phosphate buffered saline (PBS), 150 g 
sucrose and 150 ml ethylene glycol, with the final volume adjusted to 500 ml with 0.1 
M PBS.  
 
Immunohistochemistry and immunofluorescence 
BrdU labeling and double staining were performed as previously described (Lau et al., 
2007, Yau et al., 2011b). Briefly, the sections were boiled in 0.01 M citric acid (pH = 
6.0) at 95 0C for 30 min, followed by three rinses of 0.01M PBS. The sections were 
then incubated with 2 N HCl at 37 °C for 30 min in an oven, and subsequently 
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neutralized with boric acid buffer (pH = 8.5) for 15 min at room temperature. After 
three rinses with PBS, the sections were incubated with mouse anti-BrdU antibody 
(1:1000, Roche Molecular Biochemicals, Essex, UK) overnight at room temperature. 
The sections were then washed and incubated with biotinylated goat anti-mouse 
antibody (1:200, Vector Laboratories, Inc Burlingame, CA). This was followed by 
incubation with an avidin-biotin complex (Vector Laboratories), and finally the 
sections were visualized with diaminobenzidine. For co-labeling, the sections were 
incubated with primary antibodies: rat anti-BrdU antibody (1:1000, Abcam, 
Cambridge, MA) and rabbit anti-doublecortin (DCX, 1:200, Cell Signaling, Danvers 
MA) overnight in blocking diluent. Sections were then rinsed and incubated with 
Alexa Fluor 488-conjugated goat anti-rabbit and Alexa Fluor 568-conjugated goat 
anti-rat IgG (1:200, Molecular Probes, Eugene, OR) overnight at room temperature. 
After rinsing, sections were coverslipped with mounting medium.   
 
Quantification of BrdU-labeled cells and neuronal differentiation 
Brain sections were counted in one-in-twelve series of coronal sections as reported 
previously (Yau et al., 2011b). All BrdU positive cells were counted under 40X 
objective using the StereoInvestigator (MicroBrightField, Williston,VT), and only 
those within the granular cell layer (GCL) and two cell diameters below the GCL were 
counted. The resulting numbers were then multiplied by 12 to obtain the total number 
of BrdU positive cells in the dentate gyrus.  
For phenotypic analysis, thirty BrdU positive cells per animal were randomly selected 
from the dorsoventral axis of the dentate gyrus and analyzed for the co-expression of 
BrdU and DCX using fluorescence microscopy (Axioplan, Zeiss, Oberkochen, 
Germany) with 40X magnification. A cell with a BrdU-positive nucleus stained 
together with a DCX positive surrounding soma was determined as a double labeled 
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cell. The proportion of DCX positive cells over the thirty BrdU positive cells was 
obtained as the indicator for neuronal differentiation. The counting was performed in 
a blinded manner. 
 
Plasma BDNF and IGF-1 measurements 
Blood samples were collected 1-hr after injection of CORT on the last day of the 
treatment as previously performed (Yau et al., 2011b). In brief, animals were 
anaesthetized using the mixture of katemine and xylazine (2:1 ratio) and blood was 
collected from the tail vein within 3 min using a heparinized needle. Blood samples 
were then centrifuged (Eppendorf centrifuge 5417R, USA) at 1000 x g for 20 min at 4 
°C. Plasma aliquots were then stored at -80 °C until use. The BDNF and IGF-1 levels 
were determined using commercially available ELISA kits (BDNF: Chemikine BDNF 
Sandwich ELISA Kit, Millipore, Ballerica, CA;  Mouse/Rat IGF-1 Quantikine 
ELISA Kit,  R & D system, Minneapolis, MN). Sample neurotrophin levels were 
calculated from the standard curve transforming the absorbence into neurotrophin 
ceoncentrations, which presented in the unit of ng/ml.   
 
BDNF enzyme-linked immunosorbent assay  
Briefly, the BDNF standards, plasma samples (200-fold dilution) or 50μg 
hippocampal protein sample brought to 100 ul using sample diluent were added to 
96-well plate and incubated overnight with shaking at 4 °C. After washing the plate 
with wash buffer, the diluted biotinylated mouse anti-BDNF monoclonal antibody 
was added to the plate with incubated at room temperature for three hours. After 
washing, the diluted streptavidin-HRP conjugate solution was added and incubated for 
one hour at room temperature. TMB/E substrate was incubated for 15 min, followed 
by stop solution. The absorbance was immediatedly measured at 450 nm.   
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IGF-1 enzyme-linked immunosorbent assay  
The IGF-1 standard and samples (1000-fold dilution) were added to 96-well plate and 
incubated with 150 μl assay diluent for two hours at 4 °C. After washing, the plate was 
incubated with cold IGF-1 conjugate for one hour at 4 °C, followed by washings and 
30-min incubation with substrate solution at room temperature. The reaction was 
stopped by adding stop solution and absorbance was measured at 450 nm and 
corrected by subtracting reading at 570 nm.   
 
Statistical analysis 
Two-way ANOVA with running and CORT treatment as the between-subject factors 
was performed with post-hoc Fisher’s LSD test. The data of body weight change and 
spatial learning were analyzed using repeated measures ANOVA with duration as the 
within-factor, and exercise and CORT treatment as the between-subject factors. 
Student’s t-test was applied to compare two sets of data. Values were presented as 
mean ± SEM. 
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RESULTS 
 
Changes in body weight and adrenal weight by CORT treatment and running  
The adrenal to body weight ratio was measured to assess the efficacy of CORT 
injection. Acute CORT treatment for 5 days significantly decreased adrenal weight to 
body weight ratio when compared with the vehicle treatment (effect of CORT: 
F(1,22)=9.956, P=0.00037; Fig 2a.). Running did not affect the adrenal weight to 
body weight ratio (effect of running:  F(1,22)=0.169, P=0.686) and there was no 
interaction between CORT and running (CORT X running: F(1,22)=0.0004, P=0.983).  
 
Chronic CORT treatment also significantly decreased the adrenal weight to body 
weight ratio (effect of CORT: F(3,21)= 16.8, P=0.00687; Fig 2b.). In contrast, chronic 
running significantly increased the adrenal weight to body weight ratio (effect of 
running: F(3,21)=66.253, P=0.000288; interaction CORT X running: F(3,21)=64.732, 
P=0.000338). Post hoc test indicated that the CtrlR group showed a significant 
increase in the ratio compared with the CtrlN group (P <0.005), indicating that 
running increased the adrenal weight in the normal rats. CORT treatment significantly 
decreased the ratio in both non-runners and runners when compared to the 
vehicle-treated non-runners and runners, respectively (P<0.005). All rats showed an 
increase in the body weight gain during the 28-day treatment (repeated measure 
ANOVA; effect of day: F(4,92)=236.315; P<0.005). Running did not affect the body 
weight gain, but CORT significantly decreased body weight gain (effect of running: 
F(1,23)=0.007, P=0.936; effect of CORT: F(1.23)=72.283, P<0.005; Running X 
CORT : F(1,23)=6.626, P=0.019). Pos hoc test showed that CORT treatment 
significantly decreased body weight gain compared with the vehicle treatment (Fig 2c. 
Day 1, F(3,23)=0.434, P=0.731; Day 2, F(3,23)=10.275, P<0.005; Day 3, 
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F(3,23)=21.276, P<0.005; Day 4, F(3,23)=35.516, P<0.005; Day 5, F(3,23)=37.887, P 
<0.005). 
 
Depression-like phenotype of the CORT-treated rats 
We have previously validated the stress level and depression-like behavior of the 
CORT-treated rats, where the result indicates a significant elevation in CORT level 
and an increase in immobility time in the forced swim test following 14-day CORT 
injection (Yau et al., 2011b). In the present study, we assessed the behavior of 
anhedonia, a hallmark symptom of depression, which is characterized by a decrease in 
sucrose preference compared to water in the sucrose preference test. The rats with 
3-week and 4-week CORT treatment showed a decrease in sucrose preference 
compared with the vehicle-treated rats (Fig 2d. Student’s t-test, P< 0.05), indicating 
that chronic CORT treatment induced depression-like behavior in the animals. 
 
Running activity in the vehicle-treated and CORT-treated rats 
Both the vehicle-treated and CORT-treated rats gradually increased their running 
distance during the first week in acute and chronic treatment. Rats with acute CORT 
treatment showed a higher running activity relative to the vehicle-treated rats, with 
significant differences observed on Day 4 and Day 5 (Fig 3a. P<0.05). The total 
running distance was significantly higher in the CORT-treated rats relative to the 
vehicle-treated rats. (Fig 3b, Student’s t-test, P<0.05). Rats with chronic CORT 
treatment displayed a higher initial running activity during the first two weeks 
compared to vehicle-treated rats (Fig 3c. P<0.05). However, there was no significant 
difference in the total running distance in the vehicle treatment group compared to the 
CORT treatment group (Fig 3d. P>0.05).  
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Effect of acute and chronic treatment with CORT and running on hippocampal 
cell proliferation 
Neither running nor CORT treatment for 5 days affected hippocampal cell 
proliferation in the rats (Fig 4a. effect of running: F(3,20)=1.372, P=0.257); effect of 
CORT: F(3,20)=1.504, P=0.237). The data indicated that acute treatment with CORT 
and running showed no effect on modulating the proliferating rate of hippocampal 
progenitor cells.  
 
Chronic running significantly increased the number of BrdU positive cells in the 
dentate gyrus compared with the non-runners (Fig 4c. effect of running: F(3,19) 
=10.649, P=0.00517).  In contrast, chronic treatment with CORT significantly 
suppressed hippocampal cell proliferation (effect of CORT, F(3,19)=9.318, 
P=0.00806). Post hoc analysis showed a significant increase in the number of BrdU 
positive cells in the CtrlR group compared with the CtrlN group (P=0.023), indicating 
that running for 28 days significantly increased hippocampal cell proliferation in 
normal rats. Conversely, the 40mgN group showed a significant decrease in the 
number of BrdU positive cells in the dentate gyrus compared to the CtrlN group 
(P=0.046), indicating that CORT suppressed hippocampal cell proliferation. The 
40mgR group exhibited a significant increase in BrdU positive cells compared to the 
40mgN group (P=0.05), indicating running counteracted the suppressive effect of 
CORT treatment on hippocampal cell proliferation.  
 
Effect of acute and chronic treatment on hippocampal neuronal differentiation 
We examined the neuronal differentiation by quantifying the ratio of BrdU positive 
cells expressing the immature neuronal marker: doublecortin (DCX). Acute treatment 
with CORT or running showed no effect on the ratio of DCX to BrdU positive cells, 
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suggesting that neuronal differentiation was affected by neither acute CORT treatment 
nor running (Table 1 and Fig 5a. effect of running: F(3,18)=0.465, P=0.506; effect of 
CORT: F(3,18)=0.00786, P=0.931). In contrast, chronic running significantly 
increased neuronal differentiation as indicated by a significant increase in the ratio of 
DCX to BrdU positive cells in the runners compared with the non-runners (Table 1 
and Fig 5b. effect of running: F(1,20)=5,740, P=0.031) whereas chronic treatment 
with CORT suppressed neuronal differentiation (effect of CORT: F(1,20)=34.77, 
P=0.000389). Post hoc analysis showed that running significantly increased neuronal 
differentiation in the vehicle-treated rats compared with the non-runner counterparts 
(P=0.039). The 40mgN and 40mgR groups both showed a significant decrease in the 
ratio compared with the CtrlN group (P<0.05).   
 
Acute CORT treatment improved spatial learning, but not memory consolidation 
Two-way ANOVA with repeated measures showed that all rats learned to locate the 
hidden platform during the learning phase (Fig 6a. effect of day: F(4, 24)=85.575, 
P=0.000230). A significant interaction between day and CORT treatment was 
observed (day X CORT: F(4,24)=4.836, P=0.00158), but without a main effect of 
running (effect of running: F(3,24)=0.586, P=0.454). However, acute treatment with 
CORT showed a main effect on spatial learning (Fig 6a. effect of CORT: 
F(3,24)=5.136, P=0.0353). Post hoc analysis confirmed that the 40mgN and 40mgR 
groups both showed a significant decrease in the escape latency compared with the 
CtrlN group (P=0.013 and P=0.026 respectively). However, in the probe trial test, 
acute treatment with CORT or running did not affect time spent in the target area, 
indicating that memory consolidation was not affected by acute running or CORT 
treatment (Fig 6b).  
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Running reversed chronic CORT-impaired spatial learning  
Animals with chronic treatment showed that all rats learnt to locate the position of the 
hidden platform during the 5-day training period (Fig 6c. effect of day: 
F(4,24)=29.541, P=0.00087). Two-way ANOVA indicated a significant difference 
between the non-runners and runners (effect of running: F(3,24)=6.076, P=0.033). 
The 40mgN group showed a significant increase in the escape latency compared with 
the CtrlN or CtrlR groups, respectively (Day 1: P=0.024 & P=0.035 and Day 2: P 
=0.030 & P=0.015, respectively), indicating impaired spatial learning after chronic 
treatment with CORT. In contrast, running decreased escape latency as evidenced by 
the decreased escape latency in the CtrlR group compared with the 40mgN group 
(Day 4, P =0.014).  Running also reversed CORT-impaired spatial learning in the 
40mgN group as evidenced by a significant decrease in escape latency in the 40mgR 
group compared with the 40mgN group (Day 2, P=0.009). The data indicated that 
running significantly counteracted the impairment in spatial learning induced by 
CORT treatment.  
 
In the probe trial, two-way ANOVA indicated insignificant effects of running or 
CORT treatment on the time spent in the target area (Fig 6d. effect of running: 
F(3,24)=1.923, P=0.182; effect of CORT: F(3,24)=0.002; P=0.961), suggesting that 
chronic running and CORT treatment did not affect memory consolidation.  
Peripheral and central levels of BDNF after acute and chronic treatment 
We next investigated the linkage between cognitive enhancement and increase in 
peripheral BDNF and IGF-1 levels in the rats with running. We measured the plasma 
BDNF level since it has been reported that the cortex and hippocampus are the major 
sources for the increased plasma BDNF level in response to physical exercise 
(Rasmussen et al., 2009).  Two–way ANOVA indicated a significant main effect of 
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CORT on plasma BDNF level in acute treatment (Fig 7a. effect of CORT: F(3, 
20)=4.726, P=0.042). There was a significant increase in plasma BDNF level in the 
40mgN group relative to the CtrlR group (P=0.011) following acute treatment. There 
was an increased trend in plasma BDNF level in CORT-treated non-runners compared 
to the vehicle-treated non-runners, and this trend was accompanied with a significant 
elevation in hippocampal BDNF levels (Fig 7c. Student’s test, P<0.05 compared to 
the vehicle-treated non-runners).  
 
In contrast, there was no significant change in plasma BDNF level following chronic 
treatment with CORT or running (effect of running: F(3,18)=0.602, P=0.580; effect of 
CORT: F(3,18)=0.024, P=0.903). However, there was a decreased trend in plasma 
BDNF level in the CORT-treated non-runners, and this decrease was associated with a 
significant decrease in hippocampal BDNF level (Fig 7d. Student’s t-test, P<0.05 
compared to the vehicle-treated non-runners). 
 
Plasma level of IGF-1 after acute and chronic treatment 
There was no significant changes in plasma levels of IGF-1 following acute treatment 
with running and/or CORT (Fig 7b. acute: effect of running: F(3,21)=0.307, P=0.587; 
effect of  CORT: F(3,21)=3.009, P=0.101), or following the chronic treatment with 
running and/or CORT (Fig 7b. effect of running: F(3, 18)=2.564, P=0.132; effect of 
CORT: F(3, 18)=2.648, P=0.126).  
                                                                                     
DISCUSSION 
 
The present study investigated the effects of acute and chronic running on cognitive 
improvement and the correspondent changes of peripheral BDNF and IGF-1 levels in 
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the CORT-injected animal model of stress. To the best of our knowledge, this is the 
first study examining the linkage between peripheral BDNF and IGF-1 levels and 
changes in hippocampal cell proliferation in rats after running. Consistent with our 
previous findings (Yau et al., 2011b),  the result showed that chronic running 
reversed the suppression of hippocampal cell proliferation and impaired spatial 
learning by CORT treatment . However, no significant alterations of peripheral BDNF 
and IGF-1 levels after running for 28 days were observed. Interestingly, our data 
showed that acute CORT treatment increased spatial learning without altering 
hippocampal cell proliferation, which was accompanied by a significant increase in 
hippocampal BDNF levels, whereas chronic treatment with CORT impaired spatial 
learning and memory, and decreased hippocampal cell proliferation in association 
with a significant decrease in hippocampal BDNF level, but with no significant 
changes of peripheral BDNF and IGF-1 levels. 
 
The animal model of stress mimicked by subcutaneous CORT injection 
 
The CORT injected animal model of stress has been repeatedly reported to 
significantly increase plasma CORT level and cause depression-like behavior in a 
dose-dependent manner (Johnson et al., 2006, Yau et al., 2011b). The depressiongenic 
effects of the CORT injection paradigm are known to be time- and dose-dependent. 
Treatment with 40 mg/kg CORT for 14 or 21 days considerably increases 
depression-like behavior, whereas neither 20 mg/kg CORT nor 10 mg/kg CORT 
treatment produces significant increase in depression-like behavior (Gregus et al., 
2005, Johnson et al., 2006). Our previous report has shown that treatment with 20 
mg/kg CORT for 14 days exerts a beneficial effect on hippocampal plasticity (Yau et 
al., 2011c). It has also been reported that acute CORT treatment could produce 
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antidepressant-like effect (Dunn and Swiergiel, 2008, Stone and Lin, 2008) whereas 
chronic CORT treatment for 3 weeks or longer significantly increased depression-like 
behavior (Zhao et al., 2008, Zhao et al., 2009). The present study showed that the rats 
treated with CORT for 3 or 4 weeks demonstrated a behavior of anhedonia as 
evidenced by decreased sucrose preference. Our data also showed that acute (5 days) 
treatment with CORT significantly improved hippocampal-dependent learning 
whereas chronic (28 days) treatment with CORT led to learning impairment, in 
agreement with results reported by others that short-term and long-term CORT 
treatments differentially lead to positive and negative effects on animal behavior 
(Zhao et al., 2009). With reproducible findings from the same animal model, the 
protocol of repeated treatment with CORT has been validated as a reliable method for 
inducing stress in rodents in a controllable manner (Sterner and Kalynchuk, 2010).   
 
Effects of acute treatment on hippocampal cell proliferation, neurotrophins and 
spatial learning and memory 
 
Our results demonstrated the differential effects of acute and chronic treatment with 
40 mg/kg CORT on hippocampal plasticity. The acute treatment with CORT improved 
spatial learning that associated with a higher plasma BDNF levels and a significant 
increase in hippocampal BDNF levels, but did not affect hippocampal cell 
proliferation, suggesting that the positive influence of acute stress on spatial learning 
may not necessarily involve an enhancement in hippocampal cell proliferation under 
acute stress condition. It is known that acute stress is able to promote memory 
formation (Shors, 2001) and enhances acquisition up to 2 days after stressor cessation 
(Servatius and Shors, 1994). Acute exposure to stress has also been clinically shown 
to facilitate spatial navigation performance (Duncko et al., 2007). These 
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improvements in spatial learning triggered by acute stress might be due to the 
transient activation of NMDA receptor (Shors and Mathew, 1998) or increased BDNF 
level.  In fact, the association between the increase in hippocampal BDNF levels and 
improvement in spatial learning following acute CORT treatment in the present study 
suggests that the acute effect of stress on improving cognition may possibly be 
mediated by BDNF-enhanced synaptic plasticity. Our result echoed other reports that 
mRNA level of BDNF in the hippocampus can be rapidly increased by a short-time 
exposure to immobilization stress, suggesting this rapid change in BDNF expression 
may be a form of neuronal plasticity for coping with new stimuli (Marmigere et al., 
2003) as BDNF is well-known for its critical involvement in the induction of LTP and 
synaptic plasticity (Kovalchuk et al., 2002) 
 
The present data also showed that a higher level of peripheral BDNF corresponded to 
significant increase in hippocampal BDNF level and improvement in spatial learning 
following acute CORT treatment. However, there was no significant change in plasma 
BDNF level following 5-day running. A human study has shown that plasma BDNF 
level was increased after rowing exercise for 4 hr and then returned to resting levels 
after recovery for 1 hr (Rasmussen et al., 2009), indicating the transient increase in 
plasma BDNF in response to acute exercise. Acute treatment (5 days) in the present 
study may not be able to trigger substantial changes in peripheral levels of 
neurotrophins.  
 
There was no change in plasma IGF-1 levels after the acute treatment with running 
and/or CORT. The responses of peripheral IGF-1 to interventions (e.g. exercise) are 
inconsistent among studies with some reporting no alteration in serum IGF-1 levels 
(Banfi et al., 1994, Griffin et al., 2011), while others reported an increase in IGF-1 
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levels after intensive exercise training in human subjects (Hartmann and Singrun, 
1968, Schwarz et al., 1996). It has been reported that rats with one hour treadmill 
running displayed increased uptake of IGF-1 into the brain without affecting basal 
level of serum IGF-1 (Carro et al., 2000). It is possible that regulations of IGF-1 level 
in response to intervention may depend on the duration and intensity (Griffin et al., 
2011), and a significant change in peripheral IGF-1 may only be observed after 
intensive interventions.  
 
Effect of chronic treatment on hippocampal cell proliferation, neurotrophins and 
spatial learning and memory 
 
Our previous study has reported that running counteracted CORT-impaired spatial 
learning and neurogenesis following two weeks of treatment (Yau et al., 2011b).  
The beneficial effect of running on promoting hippocampal neurogenesis has also 
been shown in a genetically depressed rat model (Bjornebekk et al., 2005). We here 
confirmed our previous observation that treatment with 40 mg/kg CORT over 
4-weeks significantly decreased hippocampal cell proliferation and caused behavioral 
deficit in the water maze task that was reversed by running. From phenotypic analysis 
of newly proliferating cells, we showed that treatment with CORT over 4 weeks 
suppressed the ratio of DCX/BrdU co-labeled cells, indicating reduced neuronal 
differentiation by chronic treatment with CORT. The results echoed the finding by 
Wong and Herbert that high levels of glucocorticoid decrease neuronal differentiation 
of the surviving cells (Wong and Herbert, 2006). The suppressive effect of CORT on 
cell proliferation may result from the decreased hippocampal BDNF levels, since 
BDNF is an important neurotrophic factor for promoting neuronal survival and 
growth (Barde, 1994) the effects of which could be inhibited by high levels of CORT 
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(Rasmusson et al., 2002, Jacobsen and Mork, 2006). In fact, we have observed a 
significant decrease in hippocampal BDNF level in rats with chronic CORT treatment. 
Furthermore, our previous study has shown that running restored hippocampal cell 
proliferation in association with restored hippocampal BDNF level following a 
2-week CORT treatment (Yau et al., 2011b). As a result, the number of newborn 
neurons that can functionally integrate into neuronal circuitry of the hippocampus was 
decreased, leading to impairment in hippocampal function, and consequent behavioral 
deficits under stress condition (Yau et al., 2011b).  
 
Prolonged elevation of corticosteroid reduces the availability of hippocampal BDNF 
level (Rasmusson et al., 2002, Jacobsen and Mork, 2006) and suppresses the synthesis 
of IGF-1 in the liver (the main source of peripheral IGF-1) (Yakar et al., 1999). In the 
present study, we demonstrated that chronic CORT treatment significantly impaired 
spatial learning, suppressed cell proliferation and decreased hippocampal BDNF level, 
together with relative lower peripheral BDNF and IGF-1 levels compared to the 
vehicle-treated non-runners.  Furthermore, running promoted hippocampal cell 
proliferation in absence of changes in peripheral BDNF and IGF-1 levels in the 
vehicle-treated and CORT-treated rats. Our results indicated a trend in changes of 
peripheral BDNF levels together with a significant alteration in hippocampal cell 
proliferation following chronic treatment with CORT. However, there are studies 
showing that animals with 4-week exposure to stressful event displayed decrease in 
serum and hippocampal BDNF concentrations in association with morphological 
changes that presented in depressive disorder (Sheline et al., 1999, Duman and 
Monteggia, 2006), such as reduced hippocampal volume and neurogenesis, CA3 
dendritic retractions and decreased spine density (Blugeot et al., 2011). It has been 
reported that changes in blood BDNF level reflect the changes in the hippocampus 
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(Blugeot et al., 2011). We observed a decrease in hippocampal cell proliferation, and 
impairment in spatial learning together with a trend towards lower levels of plasma 
BDNF and IGF-1 in the non-runners with chronic CORT treatment. It is possible that 
the change in hippocampal BDNF levels was too small to be reflected in plasma 
levels in our CORT-treated rats. The changes of central BDNF might not be detectable 
in peripheral samples, though hippocampal BDNF levels have been significantly 
decreased following the 4-week CORT treatment. Furthermore, we have found that 
rats treated with 50 mg/kg CORT for two weeks showed a considerable decrease of 
BDNF levels in both hippocampus (Yau et al., 2011b) and plasma (Yau et al., 
Unpublished data). It is possible that the changes in brain BDNF levels in our 40 
mg/kg CORT-treated rats may be too small to be reflected in the peripheral levels.   
 
The results of studies reporting changes in peripheral levels of BDNF and IGF-1 after 
interventions are controversial. It has been reported that serum BDNF levels were 
up-regulated after exercise intervention in humans (Tang et al., 2008, Knaepen et al., 
2010), whereas those of IGF-1 varied after exercise (Kraemer et al., 1995, Abellan et 
al., 2006). However, there are also reports showing no change in the basal BDNF 
level in healthy subjects with a 5-week aerobic exercise training (Griffin et al., 2011).  
Furthermore, there is no change in serum BDNF level in depressive patients reflecting 
the therapeutic effects of physical exercise after 12-week training (Toups et al., 2011). 
Oppositely, it has been reported that aerobic exercise increased the size of 
hippocampus in association with increase serum BDNF level in older subjects 
(Erickson et al., 2011). It is possible that interventions triggering substantial changes 
in brain levels of neurotrophins may be critical to induce significant changes to the 
peripheral levels. 
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CONCLUSION 
Our results suggest that the beneficial effects of acute stress on cognitive 
improvement may be mediated by BDNF-enhanced synaptic plasticity in a new 
cells-independent manner, whereas the detrimental effects of chronic stress on 
cognitive impairment may be due to suppressed hippocampal cell proliferation and 
BDNF levels. Enhancement in spatial learning and elevation in hippocampal BDNF 
levels were accompanied by a corresponding increased trend in the plasma BDNF 
level following acute CORT treatment. Conversely, impairment in spatial learning, 
and suppression in hippocampal cell proliferation and decrease in hippocampal BDNF 
levels were not associated with significant peripheral changes of BDNF levels 
following chronic CORT treatment. Furthermore, the beneficial effects of running on 
hippocampal cell proliferation in normal and CORT-treated rats were in absence of 
significant alteration in peripheral levels of neurotrophins. As discussed above, it is 
possible that mild change in central levels of neurotrophins after 4-week treatment 
with running or CORT may not be reflected in peripheral levels. Since responses of 
peripheral BDNF and IGF-1 to exercise training are variable and may depend on 
duration and intensities as suggested by Griffin et al., (Griffin et al., 2011), conditions 
triggering substantial changes in the brain which can be reflected in peripheral 
neurotrophin levels warrant further investigation in attempt to show BDNF or IGF-1 
as biomarkers for the effects of exercise on cognitive improvement. 
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FIGURE LEGENDS 
 
Fig. 1. Schematic diagram showing the experimental procedures and treatment 
timeline. After two days of adaptation, rats were treated with either vehicle or CORT 
and were housed with either unlocked or locked wheels for 5 or 28 days. BrdU was 
intraperitoneally injected during the last three days of the treatment. Spatial learning 
and memory was evaluated using the water maze task one day later  and then the 
animals were sacrificed 24 hr after the test.  
 
Fig. 2. Change of body weight and adrenal weight after treatment. (a) Acute treatment 
with CORT significantly decreased adrenal to body weight ratio compared with the 
vehicle treatment. (b) Chronic treatment with CORT significantly decreased the ratio 
compared with the vehicle treatment. Running increased adrenal weight in the normal 
rats. # P <0.005 compared to the CtrlN group and CtrlR group, respectively; * 
P<0.005 compared to the CtrlN group; ** P<0.005 main effect of CORT. (c) The 
CORT-treated rats gained less body weight than the vehicle-treated rats during the 
treatment period. * P<0.005 when compared to the 40mgN group and 40mgR group, 
respectively. (d) CORT treatment for 3 or 4 weeks significantly decreased sucrose 
consumption compared with the vehicle treatment. * P < 0.05 compared to the 
vehicle-treated control group. CtrlN or CtrlR: the vehicle-treated non-runners or 
runners; 40mgN or 40mgR: 40mg/kg CORT-treated non-runners or runners. 
 
Fig. 3. Running activity of the rats with vehicle or CORT treatment. (a & b) Acute 
treatment with CORT increased the running distance when compared with the 
vehicle-treated rats with a significant difference observed on Day 4 and Day 5. Acute 
CORT treatment increased total running activity compared to the vehicle treatment. (c 
& b) The CORT-treated rats showed higher running activity relative to vehicle-treated 
  
33 
 
rats during the first 2-weeks of running. However, there was no difference in total 
running distance between the vehicle and chronic CORT treatment. * P<0.05 
compared to the vehicle-treated rats. 
 
Fig. 4. Effect of acute and chronic treatments on hippocampal cell proliferation. (a) 
Representative images showing immunohistochemical staining of BrdU positive cells 
in the dentate gyrus of the hippocampus. (b) Acute treatment with CORT or running 
did not affect the number of BrdU positive cells in the dentate gyrus. . (c) 
Representative images of BrdU positive cells after chronic treatment. (d) Chronic 
running (CtrlR) significantly increased the number of BrdU positive cells in the 
dentate gyrus when compared with the normal non-runners (CtrlN). CORT treatment 
without running (40mgN) robustly decreased the number of BrdU positive cells, 
whereas running restored the number of BrdU positive cells in rats treated with 40 
mg/kg CORT (40mgR). * P<0.05, ** P<0.005 compared to the CtrlN group. # P<0.05 
to the 40mgN group. Scale bar: 10X : 100μm; 40X: 30μm.  CtrlN or CtrlR: the 
vehicle-treated non-runners or runners; 40mgN or 40mgR: 40mg/kg CORT-treated 
non-runners or runners. 
 
Fig. 5. Acute and chronic treatment on neuronal differentiation. (a-c) Representative 
images of co-labeled cells. (d) Acute treatment with CORT or running did not affect 
the ratio of DCX to BrdU positive cells. (e) Chronic running in the vehicle-treated rats 
significantly increased the ratio of DCX to BrdU positive cells, whereas chronic 
treatment with CORT significantly decreased the ratio.  ## P<0.005 compared to the 
CtrlN group.  # P<0.005; * P<0.05 compared to the CtrlN and CtrlR groups, 
respectively. Scale bar = 50 μm. DCX: doublecortin; BrdU: 5-bromo-3-deoxyuridine 
for labeling proliferating cells; DCX: immature neuronal marker, doublecortin. CtrlN 
  
34 
 
or Ctrl R: the vehicle-treated non-runners or runners; 40mgN or 40mgR: the 40 mg/kg 
CORT-treated non-runners or runners. 
 
Fig. 6. Effects of acute and chronic treatments on spatial learning and memory (a) 
Acute treatment with CORT significantly decreased escape latency when compared 
with the vehicle treatment. Main effect of CORT: * P<0.05. (b) The time spent in the 
target area was not affected by running or CORT treatment. (c) CORT treatment in the 
non-runners significantly increased the escape latency compared with the CtrlN, CtrlR 
and 40mgR groups. * P<0.05 compared to the CtrlN and CtrlR groups on Day 1 and 
Day 2; # P<0.05 compared to the 40mgR group on Day 2. ** P<0.05 compared to the 
CtrlR group on Day 4. (d) Running showed no effects on time spent in the target area 
in rats treated with either vehicle or 40 mg/kg CORT. * P<0.05. CtrlN or Ctrl R: the 
vehicle-treated non-runners or runners; 40mgN or 40mgR: the 40 mg/kg 
CORT-treated non-runners or runners. Scale bar: 100 μm. 
 
Fig. 7. Plasma levels of BDNF and IGF-1 after acute or chronic treatment. (a ) Acute 
treatment with CORT significantly increased the plasma level of BDNF. Main effect 
of CORT: * P<0.05; # P<0.05 compared to the CORT-treated non-runners. There was 
no significant change in BDNF levels following chronic treatment. (b) Acute 
treatment with CORT and/or running did not alter plasma level of IGF. CtrlN or Ctrl 
R: the vehicle-treated non-runners or runners; 40mgN or 40mgR: the 40 mg/kg 
CORT-treated non-runners or runners. (c) Acute CORT treatment significantly 
increased hippocampal BDNF levels. (d) Chronic CORT treatment significantly 
decreased hippocampal BDNF levels 
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Table 1: Neuronal differentiation of proliferating cells in the dentate gyrus 
 Acute Chronic 
 Number of BrdU+ 
and DCX+ cells 
Co-labeled ratio Number of BrdU+ 
and DCX+ cells 
Co-labeled ratio 
CtrlN 20 ± 1.56 
 
0.66 ± 0.050 25 ± 0.51 0.79±0.031 
CtrlR 20 ± 1.69 
 
0.71 ± 0.030 26 ± 0.63 ## 0.88±0.021 ## 
40mgN 19 ± 3.41 
 
0.62 ± 0.041 21 ± 1.55 # 0.65±0.022 # 
40mgR 19 ± 1.89 
 
0.64 ± 0.052 22 ± 1.54 * 0.70±0.021* 
## P<0.005 compared to the CtrlN group.  # P<0.005; * P<0.05 compared to the 
CtrlN and CtrlR groups, respectively. 
CtrlN or Ctrl R: the vehicle-treated non-runners or runners; 40mgN or 40mgR: the 40 
mg/kg CORT-treated non-runners or runners. 
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Research Highlights 
 
? We tested changes in blood BDNF, IGF-1, cognition and neurogenesis in stressed 
rats with running 
? Acute stress enhanced cognition, blood and brain BDNF levels 
? Chronic stress impaired cognition, neurogenesis and lowered brain BDNF level 
? Running restored cognition and neurogenesis, did not alter blood neurotrophins  
? Running-improved cognition could not be reflected by blood BDNF and IGF-1 
levels 
 
 
 
 
